Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Johnson & Johnson
 More »

  • Bayer Prostate Cancer Drug Gains FDA Approval
    ... Also approved in recent years for prostate cancer have been troubled Dendreon's pricey Provenge, which has failed to live up to lofty initial sales expectations; and Johnson & ...
    5-16-2013
  • Biotechs Need to Walk the Walk on Drug Value
    ... Two months later, 10 pharma giants-AbbVie, AstraZeneca (AZ), Boehringer Ingelheim, Bristol-Myers Squibb (BMS), GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer, Roche, and ...
    5-15-2013
  • Companion Diagnostics: 52 Pick-Up
    ... Financial terms not disclosed. Metamark Genetics and Johnson & Johnson (Janssen Biotech) Agreement announced December 19, 2011 Research, collaboration, and license agreement ...
    5-9-2013
  • Another Alzheimer's Drug Fails Phase III Trial
    ... However, Lilly said in December it plans to launch by Q3 a new Phase III study of the drug in patients with mild Alzheimer's. Also last year, Johnson & Johnson's Janssen Alzheimer ...
    5-7-2013
  • New Study Shows Where to Start Your Start-Up
    ... exit via asset sale: If 50% of $50m is spent on R&D, U.K. R&D tax credits will be $6.25m. ... U.K. on the attractiveness scale for ACCs. | Partner Kevin Johnson, Ph.D. | Colin Hailey
    5-1-2013
  • The Globalization of IVD Companies
    In 2009, Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, the Ortho Clinical Diagnostics division of Johnson & Johnson, and Beckman Coulter (now Danaher) had 60% of the ...
    5-1-2013
  • Ascletis Obtains Chinese Rights to Janssen HIV Treatment
    Johnson & Johnson's Janssen subsidiary will retain all rights in the rest of the world, and is eligible to receive royalties based on product sales in greater China. "This ...
    4-30-2013
  • Merck Joins Pfizer to Develop Type 2 Diabetes Drug
    The partnership comes a month after Johnson & Johnson became the first drug developer to obtain approval in the U.S. of an SGLT2 drug-Invokana (canagliflozin) tablets for use with ...
    4-29-2013
  • Hormone Holds Promise for Replacing Insulin Injections
    Evotec said today that its CureBeta collaboration with Harvard University and Johnson & Johnson's Janssen Pharmaceuticals subsidiary has discovered a new hormone that holds promise ...
    4-26-2013
  • GEN | Biolinks
    ... Inc JDJ Bioservices Pty Ltd JDP Therapeutics Inc Johns Hopkins University Johnson & Johnson Johnson & Johnson Corporate Office of Science & Technology (COSAT) ...
  • E&Y: Biotechs Must Walk the Walk on Drug Value
    Two months later, 10 pharma giants-AbbVie, AstraZeneca (AZ), Boehringer Ingelheim, Bristol-Myers Squibb (BMS), GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer, Roche, and ...
    4-22-2013
  • Biosimilars: 10 Drugs to Watch
    ... for Epogen (Amgen), and $326 million combined for Procrit / Eprex / Erypo (Johnson & Johnson) Amgen also generated Patent status: Patent set to expire 2015 in U.S.; expired ...
    4-22-2013
  • Alzheimer's: Lilly Investment Signals R&D Shift
    ... Solanezumab wasn't the only anti-beta-amyloid monoclonal antibody to fail in Phase III. Johnson & Johnson and Pfizer ended development of bapineuzumab in August after it failed to ...
    4-17-2013
  • Cytomics for Personalized Heart Health
    ... CytoVas Location: 3160 Chestnut Street, Suite 200, Philadelphia, PA 19104 Phone: (917) 750-9605 Website: www.cytovas.com Principal: Todd Johnson, M.D. Focus: CytoVas develops ...
    4-15-2013
  • CEO Perks
    ... Non-equity incentive plan compensation, $2.5 million; Salary, $863,942 Alex Gorsky Johnson & Johnson, chairman/CEO effective April 26, 2012 Perks and "all other" compensation: ...
    4-12-2013
  • More »

    Journal Articles

  • Laparoscopic Nissen-Rossetti Fundoplication for Gastroesophageal...
    Salvatore Marano, Stefano Mattacchione, Barbara Luongo, Valentina Mingarelli, Giuseppe Campagna, Francesco Vietri, Filippo Tosato
    Journal of Laparoendoscopic& Advanced Surgical Techniquesand Part B, Videoscopy
    Journal of Laparoendoscopic& Advanced Surgical Techniquesand Part B, Videoscopy Abstract ... Patients were subjected to close follow-up. Results: The DeMeester and Johnson score ...
  • Laser Phototherapy for Stevens-Johnson Syndrome: A Case Report
    Alyne Simões, Patrícia Moreira de Freitas, Marina Stella Bello–Silva, Jan Tunér, Carlos de Paula Eduardo, Alyne Simoes, Patricia Moreira Freitas, Marina Stella Bello-Silva, Jan Tuner
    Photomedicine and Laser Surgery
    Laser Phototherapy for Stevens-Johnson Syndrome: A Case Report Photomedicine and Laser Surgery Stevens-Johnson syndrome (SJS) is a life-threatening dermatosis characterized by ...
  • Tracheal Reaction to Three Different Intraluminal Stents in an...
    Mark Weinberg, Judith Sandbank, Yoseph Flumenblit, Baruch Klin, Itzhak Vinograd
    Journal of Laparoendoscopic& Advanced Surgical Techniquesand Part B, Videoscopy
    Three different internal airway stents were studied in an animal model of tracheomalacia: the Palmaz stent (Johnson & Johnson, Warren, New Jersey) and the NIR stent (Medinol Ltd., ...
  • Peer-Professional Workgroups in Palliative Care: A Strategy for...
    Ira Byock, Jeanne Sheils Twohig, Melanie Merriman, Karyn Collins
    Journal of Palliative Medicine
    Background: As part of a comprehensive national effort to improve care at the end of life, the Promoting Excellence in End-of-Life Care program of The Robert Wood Johnson ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll